The routine practice for cervical cancer diagnosis is minimally invasive and utilizes liquid-based cytology, followed by HPV testing using commercially available p16 IHC, DNA/RNA ISH, or DNA/RNA PCR. This evidence concerns the gene CDKN2A and cervical cancer.